(2021) reported that circ‐102,166 sponge the miR‐182 expression by acting as a tumor suppressor, and reduces the cell growth, migration, invasion, and tumorigenicity of HCC by upregulating the miR‐182 targets’ MTSS1 and FOXO3a [42]. The gene discussed is FOXO3; the disease is hepatocellular carcinoma.